XB-ART-58939
Acta Physiol (Oxf)
2022 May 01;2351:e13811. doi: 10.1111/apha.13811.
Show Gene links
Show Anatomy links
ENaC activation by proteases.
Anand D
,
Hummler E
,
Rickman OJ
.
Abstract
Proteases are fundamental for a plethora of biological processes, including signalling and tissue remodelling, and dysregulated proteolytic activity can result in pathogenesis. In this review, we focus on a subclass of membrane-bound and soluble proteases that are defined as channel-activating proteases (CAPs), since they induce Na+ ion transport through an autocrine mechanism when co-expressed with the highly amiloride-sensitive epithelial sodium channel (ENaC) in Xenopus oocytes. These experiments first identified CAP1 (channel-activating protease 1, prostasin) followed by CAP2 (channel-activating protease 2, TMPRSS4) and CAP3 (channel-activating protease 3, matriptase) as in vitro mediators of ENaC current. Since then, more serine-, cysteine- and metalloproteases were confirmed as in vitro CAPs that potentially cleave and regulate ENaC, and thus this nomenclature was not further followed, but is accepted as functional term or alias. The precise mechanism of ENaC modulation by proteases has not been fully elucidated. Studies in organ-specific protease knockout models revealed evidence for their role in increasing ENaC activity, although the proteases responsible for ENaC activation are yet to be identified. We summarize recent findings in animal models of these CAPs with respect to their implication in ENaC activation. We discuss the consequences of dysregulated CAPs underlying epithelial phenotypes in pathophysiological conditions, and the role of selected protease inhibitors. We believe that these proteases may present interesting therapeutic targets for diseases with aberrant sodium homoeostasis.
PubMed ID: 35276025
PMC ID: PMC9540061
Article link: Acta Physiol (Oxf)
Grant support: [+]
31003A_182478 Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung, N-403-07-23 Swiss National Center of Competence in Research, Kidney.CH
Genes referenced: cap1 cap2
References [+] :
Alli,
Cathepsin B is secreted apically from Xenopus 2F3 cells and cleaves the epithelial sodium channel (ENaC) to increase its activity.
2012, Pubmed,
Xenbase
Alli, Cathepsin B is secreted apically from Xenopus 2F3 cells and cleaves the epithelial sodium channel (ENaC) to increase its activity. 2012, Pubmed , Xenbase
Althaus, Proteolytic ENaC activation in health and disease-a complicated puzzle. 2022, Pubmed
Andreasen, Activation of epithelial sodium channels by mouse channel activating proteases (mCAP) expressed in Xenopus oocytes requires catalytic activity of mCAP3 and mCAP2 but not mCAP1. 2006, Pubmed , Xenbase
Artunc, Proteolytic activation of the epithelial sodium channel (ENaC) by factor VII activating protease (FSAP) and its relevance for sodium retention in nephrotic mice. 2022, Pubmed , Xenbase
Berger, Renal and vascular effects of kallikrein inhibition in a model of Lonomia obliqua venom-induced acute kidney injury. 2019, Pubmed
Bohnert, Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome. 2019, Pubmed , Xenbase
Bohnert, Aprotinin prevents proteolytic epithelial sodium channel (ENaC) activation and volume retention in nephrotic syndrome. 2018, Pubmed , Xenbase
Bohnert, Experimental nephrotic syndrome leads to proteolytic activation of the epithelial Na+ channel in the mouse kidney. 2021, Pubmed
Boscardin, The function and regulation of acid-sensing ion channels (ASICs) and the epithelial Na(+) channel (ENaC): IUPHAR Review 19. 2016, Pubmed
Bruns, Epithelial Na+ channels are fully activated by furin- and prostasin-dependent release of an inhibitory peptide from the gamma-subunit. 2007, Pubmed , Xenbase
Buckley, 6-Substituted Hexamethylene Amiloride (HMA) Derivatives as Potent and Selective Inhibitors of the Human Urokinase Plasminogen Activator for Use in Cancer. 2018, Pubmed
Butterworth, Modulation of the epithelial sodium channel (ENaC) by bacterial metalloproteases and protease inhibitors. 2014, Pubmed
Buzza, Membrane-anchored serine protease matriptase regulates epithelial barrier formation and permeability in the intestine. 2010, Pubmed
Caldwell, Neutrophil elastase activates near-silent epithelial Na+ channels and increases airway epithelial Na+ transport. 2005, Pubmed
Carmeliet, Physiological consequences of loss of plasminogen activator gene function in mice. 1994, Pubmed
Chen, Regulation of epithelial sodium channels in urokinase plasminogen activator deficiency. 2014, Pubmed , Xenbase
Chen, A Comprehensive Map of mRNAs and Their Isoforms across All 14 Renal Tubule Segments of Mouse. 2021, Pubmed
Crisante, The CAP1/Prss8 catalytic triad is not involved in PAR2 activation and protease nexin-1 (PN-1) inhibition. 2014, Pubmed
Donaldson, Regulation of the epithelial sodium channel by serine proteases in human airways. 2002, Pubmed , Xenbase
Ehmke, Sodium retention by uPA in nephrotic syndrome? 2020, Pubmed
Enuka, Epithelial sodium channels (ENaC) are uniformly distributed on motile cilia in the oviduct and the respiratory airways. 2012, Pubmed
Essigke, Zymogen-locked mutant prostasin (Prss8) leads to incomplete proteolytic activation of the epithelial sodium channel (ENaC) and severely compromises triamterene tolerance in mice. 2021, Pubmed , Xenbase
Faller, Functional analysis of a missense mutation in the serine protease inhibitor SPINT2 associated with congenital sodium diarrhea. 2014, Pubmed , Xenbase
Fasquelle, Tmprss3, a transmembrane serine protease deficient in human DFNB8/10 deafness, is critical for cochlear hair cell survival at the onset of hearing. 2011, Pubmed
Frateschi, Mutations of the serine protease CAP1/Prss8 lead to reduced embryonic viability, skin defects, and decreased ENaC activity. 2012, Pubmed , Xenbase
Frateschi, PAR2 absence completely rescues inflammation and ichthyosis caused by altered CAP1/Prss8 expression in mouse skin. 2011, Pubmed
Friis, Distinct Developmental Functions of Prostasin (CAP1/PRSS8) Zymogen and Activated Prostasin. 2016, Pubmed
Garcia-Caballero, Activation of the epithelial sodium channel by the metalloprotease meprin β subunit. 2011, Pubmed , Xenbase
García-Caballero, ENaC proteolytic regulation by channel-activating protease 2. 2008, Pubmed
Gong, The Cap1-claudin-4 regulatory pathway is important for renal chloride reabsorption and blood pressure regulation. 2014, Pubmed
Guipponi, The transmembrane serine protease (TMPRSS3) mutated in deafness DFNB8/10 activates the epithelial sodium channel (ENaC) in vitro. 2002, Pubmed , Xenbase
Haerteis, Plasmin and chymotrypsin have distinct preferences for channel activating cleavage sites in the γ subunit of the human epithelial sodium channel. 2012, Pubmed , Xenbase
Haerteis, Proteolytic activation of the human epithelial sodium channel by trypsin IV and trypsin I involves distinct cleavage sites. 2014, Pubmed , Xenbase
Haerteis, Plasma kallikrein activates the epithelial sodium channel in vitro but is not essential for volume retention in nephrotic mice. 2018, Pubmed , Xenbase
Hayata, Effect of a serine protease inhibitor on the progression of chronic renal failure. 2012, Pubmed
Hinrichs, Urokinase-type plasminogen activator contributes to amiloride-sensitive sodium retention in nephrotic range glomerular proteinuria in mice. 2019, Pubmed
Hughey, Epithelial sodium channels are activated by furin-dependent proteolysis. 2004, Pubmed , Xenbase
Hummler, The channel-activating protease CAP1/Prss8 is required for placental labyrinth maturation. 2013, Pubmed
Huntley, Complex regulation of ADAR-mediated RNA-editing across tissues. 2016, Pubmed
Ji, Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites. 2015, Pubmed , Xenbase
Kawaguchi, Hepatocyte growth factor activator inhibitor-2 stabilizes Epcam and maintains epithelial organization in the mouse intestine. 2019, Pubmed
Keppner, Altered Prostasin (CAP1/Prss8) Expression Favors Inflammation and Tissue Remodeling in DSS-induced Colitis. 2016, Pubmed
Keppner, Epithelial Sodium Channel-Mediated Sodium Transport Is Not Dependent on the Membrane-Bound Serine Protease CAP2/Tmprss4. 2015, Pubmed
Keppner, Deletion of the serine protease CAP2/Tmprss4 leads to dysregulated renal water handling upon dietary potassium depletion. 2019, Pubmed
Kim, Dysregulation of ENaC in Animal Models of Nephrotic Syndrome and Liver Cirrhosis. 2006, Pubmed
Kim, Phenotypic analysis of mice lacking the Tmprss2-encoded protease. 2006, Pubmed
Kitamura, Regulation of renal sodium handling through the interaction between serine proteases and serine protease inhibitors. 2010, Pubmed
Kleyman, Regulating ENaC's gate. 2020, Pubmed
Kleyman, Epithelial Na+ Channel Regulation by Extracellular and Intracellular Factors. 2018, Pubmed
Kosa, Suppression of Tumorigenicity-14, encoding matriptase, is a critical suppressor of colitis and colitis-associated colon carcinogenesis. 2012, Pubmed
Kota, Energetic and structural basis for activation of the epithelial sodium channel by matriptase. 2012, Pubmed , Xenbase
Larionov, Cathepsin B increases ENaC activity leading to hypertension early in nephrotic syndrome. 2019, Pubmed
Law, An overview of the serpin superfamily. 2006, Pubmed
Leyvraz, The epidermal barrier function is dependent on the serine protease CAP1/Prss8. 2005, Pubmed
List, Matriptase/MT-SP1 is required for postnatal survival, epidermal barrier function, hair follicle development, and thymic homeostasis. 2002, Pubmed
List, Epithelial integrity is maintained by a matriptase-dependent proteolytic pathway. 2009, Pubmed
List, Autosomal ichthyosis with hypotrichosis syndrome displays low matriptase proteolytic activity and is phenocopied in ST14 hypomorphic mice. 2007, Pubmed
List, Deregulated matriptase causes ras-independent multistage carcinogenesis and promotes ras-mediated malignant transformation. 2005, Pubmed
Liu, Serine protease activity in m-1 cortical collecting duct cells. 2002, Pubmed
Maekawa, Camostat mesilate inhibits prostasin activity and reduces blood pressure and renal injury in salt-sensitive hypertension. 2009, Pubmed
Malsure, Colon-specific deletion of epithelial sodium channel causes sodium loss and aldosterone resistance. 2014, Pubmed
Merkin, Evolutionary dynamics of gene and isoform regulation in Mammalian tissues. 2012, Pubmed
Noreng, Molecular principles of assembly, activation, and inhibition in epithelial sodium channel. 2020, Pubmed
Noreng, Structure of the human epithelial sodium channel by cryo-electron microscopy. 2018, Pubmed
Onbe, Effect of proteinase inhibitor camostat mesilate on nephrotic syndrome with diabetic nephropathy. 1991, Pubmed
Passero, Plasmin activates epithelial Na+ channels by cleaving the gamma subunit. 2008, Pubmed , Xenbase
Passero, TMPRSS4-dependent activation of the epithelial sodium channel requires cleavage of the γ-subunit distal to the furin cleavage site. 2012, Pubmed , Xenbase
Patel, Tissue kallikrein activation of the epithelial Na channel. 2012, Pubmed , Xenbase
Peters, The membrane-anchored serine protease prostasin (CAP1/PRSS8) supports epidermal development and postnatal homeostasis independent of its enzymatic activity. 2014, Pubmed
Picard, Defective ENaC processing and function in tissue kallikrein-deficient mice. 2008, Pubmed
Planès, ENaC-mediated alveolar fluid clearance and lung fluid balance depend on the channel-activating protease 1. 2010, Pubmed
Rawlings, Twenty years of the MEROPS database of proteolytic enzymes, their substrates and inhibitors. 2016, Pubmed
Ray, Sodium retention and volume expansion in nephrotic syndrome: implications for hypertension. 2015, Pubmed
Sasamoto, Analysis of Aprotinin, a Protease Inhibitor, Action on the Trafficking of Epithelial Na+ Channels (ENaC) in Renal Epithelial Cells Using a Mathematical Model. 2017, Pubmed
Silverman, The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. 2001, Pubmed
Sugitani, Sodium absorption stimulator prostasin (PRSS8) has an anti-inflammatory effect via downregulation of TLR4 signaling in inflammatory bowel disease. 2020, Pubmed
Svenningsen, Plasmin in nephrotic urine activates the epithelial sodium channel. 2009, Pubmed , Xenbase
Svenningsen, Prostasin-dependent activation of epithelial Na+ channels by low plasmin concentrations. 2009, Pubmed
Szabo, Delineation of proteolytic and non-proteolytic functions of the membrane-anchored serine protease prostasin. 2016, Pubmed
Szabo, Reduced prostasin (CAP1/PRSS8) activity eliminates HAI-1 and HAI-2 deficiency-associated developmental defects by preventing matriptase activation. 2012, Pubmed
Szabo, Matriptase drives early-onset intestinal failure in a mouse model of congenital tufting enteropathy. 2019, Pubmed
Tang, A mouse knockout library for secreted and transmembrane proteins. 2010, Pubmed
Tomita, Control of sodium and potassium transport in the cortical collecting duct of the rat. Effects of bradykinin, vasopressin, and deoxycorticosterone. 1985, Pubmed
Uchimura, The serine protease prostasin regulates hepatic insulin sensitivity by modulating TLR4 signalling. 2014, Pubmed
Ueda, The serine protease inhibitor camostat mesilate attenuates the progression of chronic kidney disease through its antioxidant effects. 2015, Pubmed
UniProt Consortium, UniProt: the universal protein knowledgebase in 2021. 2021, Pubmed
Vallet, An epithelial serine protease activates the amiloride-sensitive sodium channel. 1997, Pubmed , Xenbase
Vuagniaux, Activation of the amiloride-sensitive epithelial sodium channel by the serine protease mCAP1 expressed in a mouse cortical collecting duct cell line. 2000, Pubmed , Xenbase
Vuagniaux, Synergistic activation of ENaC by three membrane-bound channel-activating serine proteases (mCAP1, mCAP2, and mCAP3) and serum- and glucocorticoid-regulated kinase (Sgk1) in Xenopus Oocytes. 2002, Pubmed , Xenbase
Wang, Adenovirus-mediated human prostasin gene delivery is linked to increased aldosterone production and hypertension in rats. 2003, Pubmed
Wörn, Proteasuria in nephrotic syndrome-quantification and proteomic profiling. 2021, Pubmed
Wörner, Renal effects of the serine protease inhibitor aprotinin in healthy conscious mice. 2022, Pubmed
Xiao, Plasminogen deficiency does not prevent sodium retention in a genetic mouse model of experimental nephrotic syndrome. 2021, Pubmed
Yin, Matriptase deletion initiates a Sjögren's syndrome-like disease in mice. 2014, Pubmed
Zheng, Urinary Proteolytic Activation of Renal Epithelial Na+ Channels in Chronic Heart Failure. 2016, Pubmed